Millions of medications are compounded each year in the US to meet the unique needs of patients. Compounding provides access to medication for patients who may not be able to use commercially available formulations due to dosing requirements, allergies, or rare diseases. Medications that are required to be sterile include those administered through injection, intravenous infusion (IV), intraocular (injection in the eye) or intrathecal (injection in the spine).
Understanding the risks inherent in sterile compounding and incorporating established standards are essential for patient safety. Compounded medications made without the guidance of standards may be sub-potent, super potent or contaminated, exposing patients to significant risk of adverse events or even death.
United State Pharmacopia (USP) develops standards for preparing compounded sterile medications to help ensure patient benefit and reduce risks such as contamination, infection, or incorrect dosing. “USP General Chapter <797> Pharmaceutical Compounding – Sterile Preparations”
United State Pharmacopia (USP) develops standards for preparing compounded sterile medications to help ensure patient benefit and reduce risks such as contamination, infection, or incorrect dosing. “USP General Chapter <797> Pharmaceutical Compounding – Sterile Preparations”
Acute Care Pharmaceuticals has devoted the last 15 years to providing your healthcare pharmaceutical operations with the broadest range and highest quality products to help you and your facility meet the demanding requirements of this all important USP <797> chapter.
